Persistent high-level EBNA-1 peptide antibody titers could be used to identify multiple sclerosis (MS) vs neuromyelitis optica spectrum disorder (NMOSD). Environmental factors were a barrier to ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results